Level Four Advisory Services’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

Level Four Advisory Services’s Portfolio TMBR Stock Details TMBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-4	Closed	-$7K	–	552
2018 Q4	$7K	Buy	4 +1	+33%	+$2.37K	﹤0.01%	527
2018 Q3	$9K	Buy	3 +1	+50%	+$2.89K	﹤0.01%	582
2018 Q2	$6K	Buy	2 +1	+100%	+$3.37K	﹤0.01%	611
2018 Q1	$4K	Buy	+1	New	+$2.96K	﹤0.01%	530

Other funds holding TMBR

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Level Four Advisory Services's TMBR Position: Q1 2019 in Review

Level Four Advisory Services sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q1 2019, closing a stake of 4 shares — an estimated $7K sold.

Level Four Advisory Services first reported a position in TMBR in Q1 2018 and held it in 4 quarters. The position peaked at $9K in Q3 2018. 17 funds tracked by Wall St. Rank hold TMBR as of Q1 2019.

Level Four Advisory Services reported no remaining Timber Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
Level Four Advisory Services sold 4 Timber Pharmaceuticals, Inc. shares in Q1 2019, an estimated $7K.
Level Four Advisory Services first reported a position in Timber Pharmaceuticals, Inc. in Q1 2018 and held it in 4 quarters.
Level Four Advisory Services's Timber Pharmaceuticals, Inc. position peaked at $9K in Q3 2018.
17 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q1 2019.

Based on Level Four Advisory Services's 13F filing for Q1 2019, filed 15 May 2019.